Quantum Biopharma (QNTM) Interest Expenses (2019 - 2025)
Quantum Biopharma's (QNTM) quarterly Interest Expenses came in at $158063.0 in Q4 2025, up 8330.03% year-on-year from $1875.0 in Q4 2024, and up 72.61% quarter-over-quarter from $91570.0 in Q3 2025.
Quantum Biopharma (QNTM) Interest Expenses (2019 - 2025) Analysis & Trends
Quantum Biopharma has disclosed Interest Expenses across 7 years of filings, most recently posting $158063.0 for Q4 2025.
- Interest Expenses for Q4 2025 came in at $158063.0, up 8330.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $366595.0 (up 697.34% YoY), and the FY2025 annual result was $158063.0, up 378.73% from the prior year.
- Interest Expenses came in at $158063.0 for Q4 2025 at Quantum Biopharma, up from $91570.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $158063.0 in Q4 2025 to a low of -$20902.0 in Q4 2023.
- The 5-year median for Interest Expenses is $18917.0 (2021), against an average of $29290.9.
- Across the five-year window, Interest Expenses tumbled 122.81% in 2023 and jumped 8330.03% in 2025, its largest moves.
- Quantum Biopharma's Interest Expenses stood at $18917.0 in 2021, then tumbled by 149.59% to -$9381.0 in 2022, then sank by 122.81% to -$20902.0 in 2023, then jumped by 108.97% to $1875.0 in 2024, then surged by 8330.03% to $158063.0 in 2025.
- The last three Interest Expenses figures came in at $158063.0 (Q4 2025), $91570.0 (Q3 2025), and $116962.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 12.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 158,063.00 |
| Dec 31, 2025 | 158,063.00 |
| Sep 30, 2025 | 91,570.00 |
| Sep 30, 2025 | 91,570.00 |
| Jun 30, 2025 | 116,962.00 |
| Jun 30, 2025 | 116,962.00 |
| Mar 31, 2025 | 25,374.00 |
| Mar 31, 2025 | 25,374.00 |
| Dec 31, 2024 | 1,875.00 |
| Dec 31, 2024 | 1,875.00 |
| Sep 30, 2024 | 10,371.00 |
| Sep 30, 2024 | 10,371.00 |
| Jun 30, 2024 | 8,357.00 |
| Jun 30, 2024 | 8,357.00 |
| Mar 31, 2024 | 12,414.00 |
| Mar 31, 2024 | 12,414.00 |
| Dec 31, 2023 | -20,902.00 |
| Dec 31, 2023 | -20,902.00 |
| Sep 30, 2023 | 6,130.00 |
| Sep 30, 2023 | 6,130.00 |